Skip to main content
ARROWHEAD PHARMACEUTICALS, INC. logo

ARROWHEAD PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · ARWR ISIN · US04280A1007 LEI · 549300O3CSB8T7OZ3D66 US Manufacturing
Open in API
Filings indexed 1,039 across all filing types
Latest filing 2012-02-17 Capital/Financing Update
Country US United States of America
Listing US ARWR

About ARROWHEAD PHARMACEUTICALS, INC.

https://arrowheadpharma.com/

Arrowhead Pharmaceuticals, Inc. is a biotechnology company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary RNA interference (RNAi) platform to create therapies that target disease pathways previously considered 'undruggable.' Arrowhead's development pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases. The company advances a portfolio of clinical-stage candidates designed to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
POST-EFFECTIVE AMENDMENT NO. 3 ON THE FORM S-3
Capital/Financing Update Classification · 95% confidence The document is titled 'Post-Effective Amendment No. 3 on Form S-3' and is a filing with the SEC related to deregistration of securities under a previously effective registration statement. It discusses the termination of effectiveness of a registration statement and deregistration of unsold shares. The document is a regulatory filing related to securities registration and deregistration, not a financial report, earnings release, or management discussion. It is a formal SEC filing amending a registration statement, which fits the category of Capital/Financing Update (CAP) because it relates to securities registration and capital structure changes. The document length is 7092 characters, which is substantive and contains detailed regulatory information, not just an announcement. Therefore, the best classification is Capital/Financing Update (CAP).
2012-02-17 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 9, 2012, reporting the company's fiscal 2012 first quarter financial results for the period ended December 31, 2011. The text states that the financial results are announced via a press release attached as Exhibit 99.1. The document itself is short (2789 characters) and primarily serves as a current report to announce the earnings results, not a full detailed financial report. Form 8-K filings with earnings results announcements are typically classified as Earnings Releases (ER). There is no detailed financial data or comprehensive analysis in the text, only a summary and reference to the press release. Therefore, the appropriate classification is Earnings Release (ER).
2012-02-09 English
FORM 10-Q
Interim / Quarterly Report Q1 2012
2012-02-09 English
FINAL PROSPECTUS
Capital/Financing Update Classification · 100% confidence The document is a 'Final Prospectus' filed pursuant to Rule 424(b)(3) under the Securities Act of 1933. It details the offering of 3,000,000 shares of common stock by a selling stockholder, Lincoln Park Capital Fund, LLC, under a Purchase Agreement. The text includes detailed information about the offering, risk factors, use of proceeds, and the selling stockholder, which are typical components of a prospectus related to capital raising activities. There is no indication that this is an earnings release, annual report, or other types of filings. The document is clearly related to a capital raising transaction and financing update. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is the actual prospectus, not just an announcement or a brief summary.
2012-02-02 English
Regulatory Filings 2012
Regulatory Filings
2012-01-31 English
Regulatory Filings 2012
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date for a Registration Statement on Form S-3. It is a formal communication related to a filing process but does not contain financial data, report content, or detailed disclosures itself. The document length is short (1505 characters) and it is a correspondence letter, not a report or announcement of results. This fits the category of a Regulatory Filing (RNS), which includes miscellaneous regulatory communications and filings that do not fit other categories.
2012-01-26 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.